Cambridge Innovation Capital

Cambridge Innovation Capital (CIC) is a UK-based venture capital firm with an affiliation to the University of Cambridge and has invested in over 30 companies. CIC has over £300m in AUM across life sciences and technology sectors, including artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, MedTech/diagnostics, digital health and genomics/proteomics. As a Series A investor, CIC recognizes the opportunity to instill best practices across early-stage companies.

Through its ESG Policy CIC has adopted best practices within its internal operations through energy efficiency, waste management, company culture, diversity and inclusion recruitment management, and governance compliance. CIC also embeds ESG externally through active engagement and proactively seeking investment opportunities in companies that can accelerate the transition to a low-carbon economy. CIC also ran an ESG workshop in 2021 and is developing an ESG toolkit to support portfolio companies in implementing ESG factors into their strategies. CIC is a signatory to the UN PRI to help guide decision-making within investment management processes through the Investment Committee, which considers ESG issues through the lifecycle of investment process, including pre-investment, follow-on investments and exits.